Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Shanghai Gentech Co's other current liabilities for the quarter that ended in Mar. 2026 was ¥1,341 Mil.
Shanghai Gentech Co's quarterly other current liabilities
declined
from Sep. 2025 (¥1,405 Mil) to Dec. 2025 (¥1,327 Mil) but then
increased
from Dec. 2025 (¥1,327 Mil) to Mar. 2026 (¥1,341 Mil).
Shanghai Gentech Co's annual other current liabilities
declined
from Dec. 2023 (¥2,343 Mil) to Dec. 2024 (¥1,620 Mil) and
declined
from Dec. 2024 (¥1,620 Mil) to Dec. 2025 (¥1,327 Mil).
Shanghai Gentech Co Other Current Liabilities Related Terms
Shanghai Gentech Co Other Current Liabilities Historical Data
* Premium members only.
The historical data trend for Shanghai Gentech Co's Other Current Liabilities can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shanghai Gentech Co Other Current Liabilities Chart
Shanghai Gentech Co Other Current Liabilities Calculation
The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.
What does a Other Current Liabilities of ¥1,341 Mil mean?
Shanghai Gentech Co (SHSE:688596) has a Other Current Liabilities of ¥1,341 Mil as of Mar. 2026. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Shanghai Gentech Co.
Is Shanghai Gentech Co's Other Current Liabilities too high?
Shanghai Gentech Co's current Other Current Liabilities is ¥1,341 Mil. Overall, Shanghai Gentech Co has a GF Score™ of 84/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Shanghai Gentech Co's Other Current Liabilities compare to GEV and ETN?
Shanghai Gentech Co's Other Current Liabilities of ¥1,341 Mil can be compared against companies in the Industrial Products industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for an Industrial Products company?
A good Other Current Liabilities depends on the Industrial Products industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Shanghai Gentech Co. Shanghai Gentech Co's current Other Current Liabilities is ¥1,341 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai Gentech Co stock overvalued right now?
Based on GuruFocus' analysis, Shanghai Gentech Co (SHSE:688596) is currently considered Fairly Valued. The stock's GF Value™ is ¥47.50, compared to a current price of ¥47.41 — trading 0.2% below its estimated fair value. The current Other Current Liabilities is ¥1,341 Mil. Shanghai Gentech Co's overall GF Score™ is 84/100 with 13 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For Shanghai Gentech Co (SHSE:688596), the current Other Current Liabilities is ¥1,341 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shanghai Gentech Co (SHSE:688596) Overvalued in 2026?
Based on GuruFocus' analysis, Shanghai Gentech Co stock appears to be undervalued.
The current stock price of ¥47.41 is trading 0.2% below its estimated GF Value™ of ¥47.50.
GuruFocus considers Shanghai Gentech Co to be Fairly Valued.
Key valuation signals for SHSE:688596:
Other Current Liabilities: ¥1,341 Mil
GF Value™: ¥47.50 vs. price of ¥47.41 (0.2% below fair value)
No single metric tells the full story. See the SHSE:688596 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shanghai Gentech Co Ltd is engaged in designing, production, installation and supporting services of gas chemical supply system. The company is also engaged in designing and installation of water treatment systems, recycling system, clean fluid system, and other systems.
84GF Score
Get the complete analysis for SHSE:688596
Other Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688596 has been successfully added to your 
